GlassScriptPhysician profile
Amit P Amin
NPI 1699911123
$50,586.78
in general payments reported to CMS, 2019-2025
21 companies · $2,238 in 2025
The $2,238 reported for 2025 was more than what 85% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $12K · 2021: $1,090 · 2022: $14K · 2023: $3,971 · 2024: $3,683 · 2025: $2,238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,618 · Food and Beverage: $4,274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,618.22 |
| Food and Beverage | $4,273.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $19,409.08 | 2019-2025 | Glidesheath Slender, Optitorque |
| Chiesi USA, INC. | $10,143.72 | 2019-2023 | Kengreal |
| Ge Healthcare | $9,412.59 | 2020-2024 | |
| Philips North America LLC | $3,829.46 | 2019-2025 | Coronary Other, (P88) Igt Devices Fm, (Bq9) Coronary Ivus |
| Boston Scientific Corporation | $2,312.68 | 2019-2025 | Stingray, Avvigo Guidance System, Opticross |
| Medtronic, INC. | $2,187.52 | 2022-2025 | Symplicity G3 |
| Abiomed | $705.95 | 2019-2025 | Impella |
| Abbott Laboratories | $418.67 | 2019-2021 | |
| Cardiovascular Systems INC. | $370.25 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $322.67 | 2021-2023 | Venovo |
| Heartflow, INC. | $296.47 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $251.57 | 2019-2025 | Wainua |
| Tactile Systems Technology INC | $184.28 | 2025 | Flexitouch Plus, Nimbl |
| Becton, Dickinson and Company | $165.01 | 2023 | Venclose Maven Catheter |
| Pfizer INC. | $157.83 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $120.71 | 2025 | |
| Osprey Medical INC | $108.00 | 2019 | |
| Penumbra, INC. | $103.37 | 2019 | |
| Z-Medica, LLC | $49.86 | 2019 | |
| W. L. Gore & Associates, INC. | $18.96 | 2024 | Gore Viabahn Endoprosthesis With Heparin |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.13 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Amin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.